Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04120376 · ClinicalTrials.gov registry record · NA

Reducing Adolescent Pregnancy

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
144
Enrollment target

NCT04120376: Completed NA study, sponsored by Children's Hospital of Philadelphia.

NCT04120376 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04120376, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

This multi-site study is employing a brief contraception counseling intervention in the Emergency Department (ED) to shed light on factors that affect decision making as well as barriers and facilitators to conception initiation in the Emergency Department (ED) setting. The overarching goal of the study is to reduce unintended pregnancy among females ages 15 to 18 who present to the Emergency Department (ED).

Primary Outcome

Intention to initiate contraception at Emergency Department (ED) or follow-up visit from survey responses

Interventions

  • BEHAVIORAL Contraception Counseling

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2019-11-13
Est. Completion 2021-04-30
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT04120376 record still lists

NCT04120376 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 1 intervention - of which Contraception Counseling is the first listed.

NCT04120376 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04120376 about?

NCT04120376 is a clinical study titled "Reducing Adolescent Pregnancy". This multi-site study is employing a brief contraception counseling intervention in the Emergency Department (ED) to shed light on factors that affect decision making as well as barriers and facilitators to conception initiation in the Emergency Department (ED) setting. The overarching goal of the s...

What is the current status of trial NCT04120376?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2019-11-13. Estimated completion is 2021-04-30.

What interventions are being tested in trial NCT04120376?

The interventions under investigation include: Contraception Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT04120376?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04120376's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04120376, the US trial registry maintained by the National Library of Medicine. NCT04120376 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.